Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

IGF-1 LR3 and MGF Interaction: Monitor | Peptide Database

Compound Profiles IGF-1 LR3 Modified Growth Factor Analog | Muscle Growth Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels f

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

MGF

Mechano Growth Factor | IGF-1 Splice Variant

Activates muscle satellite stem cells via receptor binding, stimulating MAPK/ERK signaling. Enhances protein synthesis and promotes muscle fiber repair.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take IGF-1 LR3 with MGF?

Yes, but with caution. Both target IGF-1 pathways; combining risks receptor overstimulation. Regular monitoring is advised.

Is IGF-1 LR3 and MGF safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between IGF-1 LR3 and MGF?

Both target IGF-1 pathways; combining risks receptor overstimulation. This assessment has 90% confidence and is based on documented research data.

How should I time IGF-1 LR3 and MGF?

IGF-1 LR3 has a half-life of 20-30 hours and MGF has a half-life of ~5-7 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching Mazdutide — share findings, ask questions, and learn from real experiences First-in-class dual GLP-1 and glucagon receptor agonist combining appetite suppression with thermogenesis stimulation. Phase 3 trials demonstrated superiority over semaglutide for weight loss and glycemic control. Dual agonist activation: GLP-1 stimulates insulin, suppresses glucagon, slows gastric emptying; Glucagon increases energy expenditure and thermogenesis while GLP-1 counteracts glucose-raising effects.

Source: peptide-db.com ↗

Research Indications

Protects blood vessels from age-related deterioration through gene expression regulation. Limits development of atherosclerotic plaques in blood vessels. Decreases endothelial dysfunction that contributes to cardiovascular disease. Regulates sirtuin 1 levels, mimicking some benefits of calorie restriction. Enhances mesenchymal stem cell proliferation and reduces senescence. Reverses senescence-associated secretory phenotype in aging cells.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Turinabol is exclusively administered orally as a 17-alpha-alkylated steroid. It is available in tablet form, typically in 10 mg and 20 mg doses from underground laboratories. The 17-alpha-methylation provides resistance to first-pass hepatic metabolism, enabling oral bioavailability but contributing to hepatic stress. Turinabol has moderate hepatotoxicity comparable to other methylated oral steroids, and liver support supplementation is recommended during use. Its 16-hour half-life allows for once- or twice-daily dosing, though split dosing provides more stable blood levels. Performance - Conservative 30-40 mg/day Split into 2 doses (morning and evening) Oral Performance - Standard 40-60 mg/day

Source: peptide-db.com ↗
Side effects

Common Side Effects

Myalgia and muscle discomfort (approximately 3-5% of users) — generally mild and less frequent than with lipophilic statins Headache Minimal liver enzyme elevation — typically transient and clinically insignificant Back pain Constipation or diarrhea

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides